On February 21, Beijing time, the San Antonio Spurs officially announced that the team's core Victor Wembanyama will miss the rest of the 2024-25 season due to deep vein thrombosis in his right shoulder.

The Spurs said Wembanyama was diagnosed with deep vein thrombosis in his right shoulder after returning to San Antonio in San Francisco. The disease causes blockage of blood flow in the veins, causing symptoms such as pain. Blood clots are usually treated with blood-thinning medications, but this often leads to an increased risk of bleeding, so players should avoid strenuous and confrontational sports while taking these medications.

According to Spurs reporter Tom Osborne, the team is optimistic about Wembanyama's long-term health. In addition, ESPN reporter Tim McMahon also reported that the Spurs expect Wembanyama to be fully recovered before the start of next season.

Spurs veteran Chris Paul said of Wembanyama's blood clot problem: "It's been very tough for all of us because we know how important Wembanyama is. It's unbelievable to think about what we've been like as a team this season. No one will feel sorry for us. ”

In addition, Kevin Love said of Wembanyama: "I was shocked, quite shocked. ”

Blood clots have had a big impact on some NBA players, including retired Chris Bosh. Of course, some players have also recovered after treatment, including Ingram, and women's tennis player Serena Williams, who was diagnosed with a pulmonary embolism in 2011.

Wembanyama has played in 46 games for the Spurs this season, averaging 24.3 points, 11.0 rebounds, 3.7 assists and 3.8 blocks per game while shooting 47.6 percent from the field.